{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:14:18Z","timestamp":1793938458293,"version":"4.8.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41574-020-00451-4","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T07:02:52Z","timestamp":1611039772000},"page":"195-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":616,"title":["Current understanding of the molecular and cellular pathology of diabetic retinopathy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1130-6577","authenticated-orcid":false,"given":"David A.","family":"Antonetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-9348","authenticated-orcid":false,"given":"Paolo S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"451_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"K Ogurtsova","year":"2017","unstructured":"Ogurtsova, K. et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 128, 40\u201350 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"451_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/08820538.2015.1114833","volume":"31","author":"RS Ajlan","year":"2016","unstructured":"Ajlan, R. S., Silva, P. S. & Sun, J. K. Vascular endothelial growth factor and diabetic retinal disease. Semin. Ophthalmol. 31, 40\u201348 (2016).","journal-title":"Semin. Ophthalmol."},{"key":"451_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/17469899.2020.1806713","volume":"15","author":"AS Li","year":"2020","unstructured":"Li, A. S., Veerappan, M., Mittal, V. & Do, D. V. Anti-VEGF agents in the management of diabetic macular edema. Expert Rev. Ophthalmol. 15, 285\u2013296 (2020).","journal-title":"Expert Rev. Ophthalmol."},{"key":"451_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","volume":"98","author":"[No authors listed]","year":"1991","unstructured":"[No authors listed]. Grading diabetic retinopathy from stereoscopic color fundus photographs\u2013an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98, 786\u2013806 (1991).","journal-title":"Ophthalmology"},{"key":"451_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2337\/dc16-2641","volume":"40","author":"SD Solomon","year":"2017","unstructured":"Solomon, S. D. et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care 40, 412\u2013418 (2017).","journal-title":"Diabetes Care"},{"key":"451_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2337\/diab.44.6.603","volume":"44","author":"EM Kohner","year":"1995","unstructured":"Kohner, E. M., Patel, V. & Rassam, S. M. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44, 603\u2013607 (1995).","journal-title":"Diabetes"},{"key":"451_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3109\/02713683.2010.514659","volume":"35","author":"S Roy","year":"2010","unstructured":"Roy, S., Ha, J., Trudeau, K. & Beglova, E. Vascular basement membrane thickening in diabetic retinopathy. Curr. Eye Res. 35, 1045\u20131056 (2010).","journal-title":"Curr. Eye Res."},{"key":"451_CR8","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1093\/emboj\/cdf418","volume":"21","author":"M Enge","year":"2002","unstructured":"Enge, M. et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21, 4307\u20134316 (2002).","journal-title":"EMBO J."},{"key":"451_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0161-6420(13)38014-2","volume":"98","author":"[No authors listed]","year":"1991","unstructured":"[No authors listed]. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98, 823\u2013833 (1991).","journal-title":"Ophthalmology"},{"key":"451_CR10","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","volume":"115","author":"R Klein","year":"2008","unstructured":"Klein, R. et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115, 1859\u20131868 (2008).","journal-title":"Ophthalmology"},{"key":"451_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ophtha.2006.06.052","volume":"114","author":"DJ Browning","year":"2007","unstructured":"Browning, D. J. et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114, 525\u2013536 (2007).","journal-title":"Ophthalmology"},{"key":"451_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1755-3768.2009.01545.x","volume":"87","author":"TW Gardner","year":"2009","unstructured":"Gardner, T. W., Larsen, M., Girach, A. & Zhi, X. Diabetic macular oedema and visual loss: relationship to location, severity and duration. Acta Ophthalmol. 87, 709\u2013713 (2009).","journal-title":"Acta Ophthalmol."},{"key":"451_CR13","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","volume":"103","author":"[No authors listed]","year":"1985","unstructured":"[No authors listed]. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch. Ophthalmol. 103, 1796\u20131806 (1985).","journal-title":"Arch. Ophthalmol."},{"key":"451_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000455265","volume":"58","author":"J Cunha-Vaz","year":"2017","unstructured":"Cunha-Vaz, J. Mechanisms of retinal fluid accumulation and blood-retinal barrier breakdown. Dev. Ophthalmol. 58, 11\u201320 (2017).","journal-title":"Dev. Ophthalmol."},{"key":"451_CR15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1152\/jn.00761.2014","volume":"113","author":"IS Samuels","year":"2015","unstructured":"Samuels, I. S., Bell, B. A., Pereira, A., Saxon, J. & Peachey, N. S. Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes. J. Neurophysiol. 113, 1085\u20131099 (2015).","journal-title":"J. Neurophysiol."},{"key":"451_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/ncb2926","volume":"16","author":"K Bentley","year":"2014","unstructured":"Bentley, K. et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat. Cell Biol. 16, 309\u2013321 (2014).","journal-title":"Nat. Cell Biol."},{"key":"451_CR17","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1167\/iovs.15-18397","volume":"57","author":"DM Desjardins","year":"2016","unstructured":"Desjardins, D. M. et al. Progressive early breakdown of retinal pigment epithelium function in hyperglycemic rats. Invest. Ophthalmol. Vis. Sci. 57, 2706\u20132713 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR18","doi-asserted-by":"publisher","first-page":"ORSF81","DOI":"10.1167\/iovs.13-12979","volume":"54","author":"GA Lutty","year":"2013","unstructured":"Lutty, G. A. Effects of diabetes on the eye. Invest. Ophthalmol. Vis. Sci. 54, ORSF81\u2013ORSF87 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR19","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson, C. P. et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110, 1677\u20131682 (2003).","journal-title":"Ophthalmology"},{"key":"451_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1167\/iovs.17-21873","volume":"59","author":"MD Abramoff","year":"2018","unstructured":"Abramoff, M. D. et al. Approach for a clinically useful comprehensive classification of vascular and neural aspects of diabetic retinal disease. Invest. Ophthalmol. Vis. Sci. 59, 519\u2013527 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/09286580701396720","volume":"14","author":"BE Klein","year":"2007","unstructured":"Klein, B. E. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 14, 179\u2013183 (2007).","journal-title":"Ophthalmic Epidemiol."},{"key":"451_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0161-6420(95)31052-4","volume":"102","author":"R Klein","year":"1995","unstructured":"Klein, R., Klein, B. E., Moss, S. E. & Cruickshanks, K. J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102, 7\u201316 (1995).","journal-title":"Ophthalmology"},{"key":"451_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93751","volume":"2","author":"EJ Duh","year":"2017","unstructured":"Duh, E. J., Sun, J. K. & Stitt, A. W. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight 2, e93751 (2017).","journal-title":"JCI Insight"},{"key":"451_CR24","doi-asserted-by":"crossref","unstructured":"Klein, R. in Diabetic Retinopathy Ch. 3 (ed. Duh, E.) 67\u2013107 (Humana, 2008).","DOI":"10.1007\/978-1-59745-563-3_3"},{"key":"451_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2337\/db17-1034","volume":"67","author":"NM Kady","year":"2018","unstructured":"Kady, N. M. et al. ELOVL4-mediated production of very long-chain ceramides stabilizes tight junctions and prevents diabetes-induced retinal vascular permeability. Diabetes 67, 769\u2013781 (2018).","journal-title":"Diabetes"},{"key":"451_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2337\/db09-0728","volume":"59","author":"M Tikhonenko","year":"2010","unstructured":"Tikhonenko, M. et al. Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 59, 219\u2013227 (2010).","journal-title":"Diabetes"},{"key":"451_CR27","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.ophtha.2013.05.004","volume":"120","author":"PS Silva","year":"2013","unstructured":"Silva, P. S. et al. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology 120, 2587\u20132595 (2013).","journal-title":"Ophthalmology"},{"key":"451_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jdiacomp.2014.08.009","volume":"29","author":"ML Rasmussen","year":"2015","unstructured":"Rasmussen, M. L. et al. Comparison between early treatment diabetic retinopathy study 7-field retinal photos and non-mydriatic, mydriatic and mydriatic steered widefield scanning laser ophthalmoscopy for assessment of diabetic retinopathy. J. Diabetes Complications 29, 99\u2013104 (2015).","journal-title":"J. Diabetes Complications"},{"key":"451_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ophtha.2015.01.008","volume":"122","author":"PS Silva","year":"2015","unstructured":"Silva, P. S. et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology 122, 949\u2013956 (2015).","journal-title":"Ophthalmology"},{"key":"451_CR30","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/bjophthalmol-2015-306719","volume":"99","author":"SJ Talks","year":"2015","unstructured":"Talks, S. J., Manjunath, V., Steel, D. H., Peto, T. & Taylor, R. New vessels detected on wide-field imaging compared to two-field and seven-field imaging: implications for diabetic retinopathy screening image analysis. Br. J. Ophthalmol. 99, 1606\u20131609 (2015).","journal-title":"Br. J. Ophthalmol."},{"key":"451_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamaophthalmol.2018.4982","volume":"137","author":"LP Aiello","year":"2019","unstructured":"Aiello, L. P. et al. Comparison of early treatment diabetic retinopathy study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy. JAMA Ophthalmol. 137, 65\u201373 (2019).","journal-title":"JAMA Ophthalmol."},{"key":"451_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/IAE.0b013e3182278b64","volume":"32","author":"MM Wessel","year":"2012","unstructured":"Wessel, M. M. et al. Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina 32, 785\u2013791 (2012).","journal-title":"Retina"},{"key":"451_CR33","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.ophtha.2015.07.034","volume":"122","author":"PS Silva","year":"2015","unstructured":"Silva, P. S. et al. Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography. Ophthalmology 122, 2465\u20132472 (2015).","journal-title":"Ophthalmology"},{"key":"451_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamaophthalmol.2015.3949","volume":"134","author":"E Korot","year":"2016","unstructured":"Korot, E., Comer, G., Steffens, T. & Antonetti, D. A. Algorithm for the measure of vitreous hyperreflective foci in optical coherence tomographic scans of patients with diabetic macular edema. JAMA Ophthalmol. 134, 15\u201320 (2016).","journal-title":"JAMA Ophthalmol."},{"key":"451_CR35","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1364\/OE.20.004710","volume":"20","author":"Y Jia","year":"2012","unstructured":"Jia, Y. et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt. Express 20, 4710\u20134725 (2012).","journal-title":"Opt. Express"},{"key":"451_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/IAE.0000000000001990","volume":"39","author":"S Vujosevic","year":"2019","unstructured":"Vujosevic, S. et al. Early microvascular and neural changes in patients with type 1 and type 2 diabetes mellitus without clinical signs of diabetic retinopathy. Retina 39, 435\u2013445 (2019).","journal-title":"Retina"},{"key":"451_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide, R. F., Fujimoto, J. G., Waheed, N. K., Sadda, S. R. & Staurenghi, G. Optical coherence tomography angiography. Prog. Retin. Eye Res. 64, 1\u201355 (2018).","journal-title":"Prog. Retin. Eye Res."},{"key":"451_CR38","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1021\/acs.jproteome.8b00169","volume":"17","author":"NR Haines","year":"2018","unstructured":"Haines, N. R., Manoharan, N., Olson, J. L., D\u2019Alessandro, A. & Reisz, J. A. Metabolomics analysis of human vitreous in diabetic retinopathy and rhegmatogenous retinal detachment. J. Proteome Res. 17, 2421\u20132427 (2018).","journal-title":"J. Proteome Res."},{"key":"451_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11892-017-0939-3","volume":"17","author":"G Liew","year":"2017","unstructured":"Liew, G. et al. Metabolomics of diabetic retinopathy. Curr. Diab. Rep. 17, 102 (2017).","journal-title":"Curr. Diab. Rep."},{"key":"451_CR40","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0161-6420(98)96025-0","volume":"105","author":"SE Moss","year":"1998","unstructured":"Moss, S. E., Klein, R. & Klein, B. E. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105, 998\u20131003 (1998).","journal-title":"Ophthalmology"},{"key":"451_CR41","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/S0161-6420(98)91020-X","volume":"105","author":"R Klein","year":"1998","unstructured":"Klein, R., Klein, B. E., Moss, S. E. & Cruickshanks, K. J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105, 1801\u20131815 (1998).","journal-title":"Ophthalmology"},{"key":"451_CR42","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/glia.21068","volume":"58","author":"A Mishra","year":"2010","unstructured":"Mishra, A. & Newman, E. A. Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy. Glia 58, 1996\u20132004 (2010).","journal-title":"Glia"},{"key":"451_CR43","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1167\/iovs.09-3442","volume":"50","author":"TT Nguyen","year":"2009","unstructured":"Nguyen, T. T. et al. Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest. Ophthalmol. Vis. Sci. 50, 5609\u20135613 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2337\/diabetes.55.03.06.db05-1349","volume":"55","author":"T Pannicke","year":"2006","unstructured":"Pannicke, T. et al. Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes 55, 633\u2013639 (2006).","journal-title":"Diabetes"},{"key":"451_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193280","volume":"13","author":"K Thompson","year":"2018","unstructured":"Thompson, K. et al. Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal Muller cells. PLoS ONE 13, e0193280 (2018).","journal-title":"PLoS ONE"},{"key":"451_CR46","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1007\/s00125-018-4707-y","volume":"61","author":"RE McDowell","year":"2018","unstructured":"McDowell, R. E. et al. Muller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine. Diabetologia 61, 2654\u20132667 (2018).","journal-title":"Diabetologia"},{"key":"451_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/db16-0051","volume":"66","author":"JC Portillo","year":"2017","unstructured":"Portillo, J. C. et al. CD40 in retinal Muller cells induces P2X7-dependent cytokine expression in macrophages\/microglia in diabetic mice and development of early experimental diabetic retinopathy. Diabetes 66, 483\u2013493 (2017).","journal-title":"Diabetes"},{"key":"451_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","volume":"45","author":"M Karlstetter","year":"2015","unstructured":"Karlstetter, M. et al. Retinal microglia: just bystander or target for therapy? Prog. Retin. Eye Res. 45, 30\u201357 (2015).","journal-title":"Prog. Retin. Eye Res."},{"key":"451_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/jama.298.8.902","volume":"298","author":"Q Mohamed","year":"2007","unstructured":"Mohamed, Q., Gillies, M. C. & Wong, T. Y. Management of diabetic retinopathy: a systematic review. JAMA 298, 902\u2013916 (2007).","journal-title":"JAMA"},{"key":"451_CR50","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc13-2002","volume":"37","author":"R Simo","year":"2014","unstructured":"Simo, R., Sundstrom, J. M. & Antonetti, D. A. Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care 37, 893\u2013899 (2014).","journal-title":"Diabetes Care"},{"key":"451_CR51","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.2337\/db12-1744","volume":"62","author":"PM Titchenell","year":"2013","unstructured":"Titchenell, P. M. & Antonetti, D. A. Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy. Diabetes 62, 1808\u20131815 (2013).","journal-title":"Diabetes"},{"key":"451_CR52","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen, Q. D. et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119, 789\u2013801 (2012).","journal-title":"Ophthalmology"},{"key":"451_CR53","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.ophtha.2012.02.010","volume":"119","author":"DV Do","year":"2012","unstructured":"Do, D. V. et al. One-year outcomes of the DA VINCI study of VEGF trap-eye in eyes with diabetic macular edema. Ophthalmology 119, 1658\u20131665 (2012).","journal-title":"Ophthalmology"},{"key":"451_CR54","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1016\/j.ophtha.2016.07.032","volume":"123","author":"JS Heier","year":"2016","unstructured":"Heier, J. S. et al. Intravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studies. Ophthalmology 123, 2376\u20132385 (2016).","journal-title":"Ophthalmology"},{"key":"451_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ophtha.2018.08.001","volume":"126","author":"JK Sun","year":"2019","unstructured":"Sun, J. K. et al. Rationale and application of the protocol S anti-vascular endothelial growth factor algorithm for proliferative diabetic retinopathy. Ophthalmology 126, 87\u201395 (2019).","journal-title":"Ophthalmology"},{"key":"451_CR56","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Wells, J. A. et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N. Engl. J. Med. 372, 1193\u20131203 (2015).","journal-title":"N. Engl. J. Med."},{"key":"451_CR57","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/db19-1121","volume":"69","author":"M Arima","year":"2020","unstructured":"Arima, M. et al. Claudin-5 redistribution induced by inflammation leads to anti-VEGF-resistant diabetic macular edema. Diabetes 69, 981\u2013999 (2020).","journal-title":"Diabetes"},{"key":"451_CR58","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","volume":"146","author":"M Potente","year":"2011","unstructured":"Potente, M., Gerhardt, H. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis. Cell 146, 873\u2013887 (2011).","journal-title":"Cell"},{"key":"451_CR59","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1073\/pnas.1814711116","volume":"116","author":"K Miloudi","year":"2019","unstructured":"Miloudi, K. et al. NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy. Proc. Natl Acad. Sci. USA 116, 4538\u20134547 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"451_CR60","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman, R., Zhou, L., Kebede, A. A. & Barres, B. A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562\u2013566 (2010).","journal-title":"Nature"},{"key":"451_CR61","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1101\/gad.266803","volume":"17","author":"P Lindblom","year":"2003","unstructured":"Lindblom, P. et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17, 1835\u20131840 (2003).","journal-title":"Genes Dev."},{"key":"451_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15296","volume":"8","author":"DY Park","year":"2017","unstructured":"Park, D. Y. et al. Plastic roles of pericytes in the blood-retinal barrier. Nat. Commun. 8, 15296 (2017).","journal-title":"Nat. Commun."},{"key":"451_CR63","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/nm.2052","volume":"15","author":"P Geraldes","year":"2009","unstructured":"Geraldes, P. et al. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat. Med. 15, 1298\u20131306 (2009).","journal-title":"Nat. Med."},{"key":"451_CR64","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","volume":"106","author":"P Geraldes","year":"2010","unstructured":"Geraldes, P. & King, G. L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 106, 1319\u20131331 (2010).","journal-title":"Circ. Res."},{"key":"451_CR65","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0092-8674(04)00216-8","volume":"116","author":"Q Xu","year":"2004","unstructured":"Xu, Q. et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116, 883\u2013895 (2004).","journal-title":"Cell"},{"key":"451_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2009.07.047","volume":"139","author":"X Ye","year":"2009","unstructured":"Ye, X. et al. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 139, 285\u2013298 (2009).","journal-title":"Cell"},{"key":"451_CR67","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2012.10.042","volume":"151","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Norrin\/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell 151, 1332\u20131344 (2012).","journal-title":"Cell"},{"key":"451_CR68","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1172\/JCI76431","volume":"124","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y. et al. Canonical WNT signaling components in vascular development and barrier formation. J. Clin. Invest. 124, 3825\u20133846 (2014).","journal-title":"J. Clin. Invest."},{"key":"451_CR69","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1167\/iovs.12-10127","volume":"54","author":"CC Tokunaga","year":"2013","unstructured":"Tokunaga, C. C., Chen, Y. H., Dailey, W., Cheng, M. & Drenser, K. A. Retinal vascular rescue of oxygen-induced retinopathy in mice by norrin. Invest. Ophthalmol. Vis. Sci. 54, 222\u2013229 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1523\/JNEUROSCI.3210-09.2010","volume":"30","author":"A Ohlmann","year":"2010","unstructured":"Ohlmann, A. et al. Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice. J. Neurosci. 30, 183\u2013193 (2010).","journal-title":"J. Neurosci."},{"key":"451_CR71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.exer.2015.12.001","volume":"145","author":"LF Zeilbeck","year":"2016","unstructured":"Zeilbeck, L. F. et al. Norrin mediates angiogenic properties via the induction of insulin-like growth factor-1. Exp. Eye Res. 145, 317\u2013326 (2016).","journal-title":"Exp. Eye Res."},{"key":"451_CR72","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1074\/jbc.RA119.011273","volume":"295","author":"M Diaz-Coranguez","year":"2020","unstructured":"Diaz-Coranguez, M., Lin, C. M., Liebner, S. & Antonetti, D. A. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability. J. Biol. Chem. 295, 4647\u20134660 (2020).","journal-title":"J. Biol. Chem."},{"key":"451_CR73","doi-asserted-by":"publisher","first-page":"872978","DOI":"10.1155\/2012\/872978","volume":"2012","author":"O Simo-Servat","year":"2012","unstructured":"Simo-Servat, O., Hernandez, C. & Simo, R. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm. 2012, 872978 (2012).","journal-title":"Mediators Inflamm."},{"key":"451_CR74","doi-asserted-by":"publisher","first-page":"BIO68","DOI":"10.1167\/iovs.17-21769","volume":"58","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic, S. & Simo, R. Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach. Invest. Ophthalmol. Vis. Sci. 58, BIO68\u2013BIO75 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR75","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1096\/fj.01-0707fje","volume":"16","author":"AM Joussen","year":"2002","unstructured":"Joussen, A. M. et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-\u03b1 suppression. FASEB J. 16, 438\u2013440 (2002).","journal-title":"FASEB J."},{"key":"451_CR76","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1167\/iovs.10-5768","volume":"52","author":"H Huang","year":"2011","unstructured":"Huang, H. et al. TNF\u03b1 is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest. Ophthalmol. Vis. Sci. 52, 1336\u20131344 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR77","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","volume":"18","author":"AM Joussen","year":"2004","unstructured":"Joussen, A. M. et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18, 1450\u20131452 (2004).","journal-title":"FASEB J."},{"key":"451_CR78","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/sj.eye.6702138","volume":"20","author":"N Demircan","year":"2005","unstructured":"Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A. & Sizmaz, S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20, 1366\u20131369 (2005).","journal-title":"Eye"},{"key":"451_CR79","first-page":"44","volume":"53","author":"DN Koleva-Georgieva","year":"2011","unstructured":"Koleva-Georgieva, D. N., Sivkova, N. P. & Terzieva, D. Serum inflammatory cytokines IL-1\u03b2, IL-6, TNF-\u03b1 and VEGF have influence on the development of diabetic retinopathy. Folia Med. 53, 44\u201350 (2011).","journal-title":"Folia Med."},{"key":"451_CR80","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1167\/iovs.12-10410","volume":"53","author":"SD Schoenberger","year":"2012","unstructured":"Schoenberger, S. D. et al. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy and correlation with VEGF and inflammatory cytokines. Invest. Ophthalmol. Vis. Sci. 53, 5906\u20135911 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008158","volume":"4","author":"T Yoshimura","year":"2009","unstructured":"Yoshimura, T. et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 4, e8158 (2009).","journal-title":"PLoS ONE"},{"key":"451_CR82","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0002-9394(01)01008-X","volume":"132","author":"N Ogata","year":"2001","unstructured":"Ogata, N. et al. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am. J. Ophthalmol. 132, 378\u2013382 (2001).","journal-title":"Am. J. Ophthalmol."},{"key":"451_CR83","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.2337\/db09-1606","volume":"59","author":"CA Aveleira","year":"2010","unstructured":"Aveleira, C. A., Lin, C. M., Abcouwer, S. F., Ambrosio, A. F. & Antonetti, D. A. TNF-\u03b1 signals through PKC\u03b6\/NF-\u03baB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes 59, 2872\u20132882 (2010).","journal-title":"Diabetes"},{"key":"451_CR84","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1042\/BJ20111961","volume":"446","author":"PM Titchenell","year":"2012","unstructured":"Titchenell, P. M. et al. Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction. Biochem. J. 446, 455\u2013467 (2012).","journal-title":"Biochem. J."},{"key":"451_CR85","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.ajpath.2018.06.020","volume":"188","author":"CM Lin","year":"2018","unstructured":"Lin, C. M. et al. Inhibition of atypical protein kinase C reduces inflammation-induced retinal vascular permeability. Am. J. Pathol. 188, 2392\u20132405 (2018).","journal-title":"Am. J. Pathol."},{"key":"451_CR86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.visres.2017.03.006","volume":"139","author":"TW Gardner","year":"2017","unstructured":"Gardner, T. W. & Sundstrom, J. M. A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping. Vis. Res. 139, 153\u2013160 (2017).","journal-title":"Vis. Res."},{"key":"451_CR87","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/dc10-1675","volume":"34","author":"JK Sun","year":"2011","unstructured":"Sun, J. K. et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-Year Medalist Study. Diabetes Care 34, 968\u2013974 (2011).","journal-title":"Diabetes Care"},{"key":"451_CR88","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/157339910793360815","volume":"6","author":"A Praidou","year":"2010","unstructured":"Praidou, A. et al. Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr. Diabetes Rev. 6, 304\u2013312 (2010).","journal-title":"Curr. Diabetes Rev."},{"key":"451_CR89","doi-asserted-by":"publisher","first-page":"eaau6627","DOI":"10.1126\/scitranslmed.aau6627","volume":"11","author":"H Yokomizo","year":"2019","unstructured":"Yokomizo, H. et al. Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy. Sci. Transl. Med. 11, eaau6627 (2019).","journal-title":"Sci. Transl. Med."},{"key":"451_CR90","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00125-009-1548-8","volume":"52","author":"M Garcia-Ramirez","year":"2009","unstructured":"Garcia-Ramirez, M. et al. Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia 52, 2633\u20132641 (2009).","journal-title":"Diabetologia"},{"key":"451_CR91","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1534","volume":"13","author":"BB Gao","year":"2007","unstructured":"Gao, B. B. et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 13, 181\u2013188 (2007).","journal-title":"Nat. Med."},{"key":"451_CR92","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.2337\/db10-1260","volume":"60","author":"A Clermont","year":"2011","unstructured":"Clermont, A. et al. Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats. Diabetes 60, 1590\u20131598 (2011).","journal-title":"Diabetes"},{"key":"451_CR93","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1172\/JCI120879","volume":"129","author":"A Sodhi","year":"2019","unstructured":"Sodhi, A. et al. Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema. J. Clin. Invest. 129, 4593\u20134608 (2019).","journal-title":"J. Clin. Invest."},{"key":"451_CR94","doi-asserted-by":"publisher","first-page":"E3425","DOI":"10.1073\/pnas.1217091110","volume":"110","author":"X Xin","year":"2013","unstructured":"Xin, X. et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc. Natl Acad. Sci. USA 110, E3425\u2013E3434 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"451_CR95","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1093\/eurheartj\/eht153","volume":"34","author":"C Bouleti","year":"2013","unstructured":"Bouleti, C. et al. Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke. Eur. Heart J. 34, 3657\u20133668 (2013).","journal-title":"Eur. Heart J."},{"key":"451_CR96","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125437","volume":"4","author":"DI Cho","year":"2019","unstructured":"Cho, D. I. et al. Antiinflammatory activity of ANGPTL4 facilitates macrophage polarization to induce cardiac repair. JCI Insight 4, e125437 (2019).","journal-title":"JCI Insight"},{"key":"451_CR97","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2013.09.003","volume":"18","author":"A Cerani","year":"2013","unstructured":"Cerani, A. et al. Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab. 18, 505\u2013518 (2013).","journal-title":"Cell Metab."},{"key":"451_CR98","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature12345","volume":"499","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. LRG1 promotes angiogenesis by modulating endothelial TGF-\u03b2 signalling. Nature 499, 306\u2013311 (2013).","journal-title":"Nature"},{"key":"451_CR99","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.25.218149","author":"D Kallenberg","year":"2020","unstructured":"Kallenberg, D. et al. A humanized antibody against LRG1 that inhibits angiogenesis and reduces retinal vascular leakage. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.07.25.218149 (2020).","journal-title":"bioRxiv"},{"key":"451_CR100","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1167\/iovs.18-24548","volume":"59","author":"AJ Duraisamy","year":"2018","unstructured":"Duraisamy, A. J., Mishra, M., Kowluru, A. & Kowluru, R. A. Epigenetics and regulation of oxidative stress in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 59, 4831\u20134840 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR101","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.visres.2017.02.011","volume":"139","author":"RA Kowluru","year":"2017","unstructured":"Kowluru, R. A. Diabetic retinopathy, metabolic memory and epigenetic modifications. Vis. Res. 139, 30\u201338 (2017).","journal-title":"Vis. Res."},{"key":"451_CR102","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI2425","volume":"102","author":"AJ Barber","year":"1998","unstructured":"Barber, A. J. et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 102, 783\u2013791 (1998).","journal-title":"J. Clin. Invest."},{"key":"451_CR103","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"113","author":"EH Sohn","year":"2016","unstructured":"Sohn, E. H. et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc. Natl Acad. Sci. USA 113, E2655\u2013E2664 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"451_CR104","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/archophthalmol.2010.362","volume":"129","author":"TW Gardner","year":"2011","unstructured":"Gardner, T. W., Abcouwer, S. F., Barber, A. J. & Jackson, G. R. An integrated approach to diabetic retinopathy research. Arch. Ophthalmol. 129, 230\u2013235 (2011).","journal-title":"Arch. Ophthalmol."},{"key":"451_CR105","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.visres.2017.03.003","volume":"139","author":"SK Lynch","year":"2017","unstructured":"Lynch, S. K. & Abramoff, M. D. Diabetic retinopathy is a neurodegenerative disorder. Vis. Res. 139, 101\u2013107 (2017).","journal-title":"Vis. Res."},{"key":"451_CR106","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2337\/db17-0728","volume":"67","author":"WP Miller","year":"2018","unstructured":"Miller, W. P. et al. Deletion of the Akt\/mTORC1 repressor REDD1 prevents visual dysfunction in a rodent model of type 1 diabetes. Diabetes 67, 110\u2013119 (2018).","journal-title":"Diabetes"},{"key":"451_CR107","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.3390\/ijms19113578","volume":"19","author":"P Bogdanov","year":"2018","unstructured":"Bogdanov, P. et al. Topical administration of bosentan prevents retinal neurodegeneration in experimental diabetes. Int. J. Mol. Sci. 19, 3578 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"451_CR108","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2337\/db16-1453","volume":"66","author":"AR Santos","year":"2017","unstructured":"Santos, A. R. et al. Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project. Diabetes 66, 2503\u20132510 (2017).","journal-title":"Diabetes"},{"key":"451_CR109","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C. & Scheltens, P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5, 64\u201374 (2006).","journal-title":"Lancet Neurol."},{"key":"451_CR110","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-2009-1011","volume":"16","author":"D Kopf","year":"2009","unstructured":"Kopf, D. & Frolich, L. Risk of incident Alzheimer\u2019s disease in diabetic patients: a systematic review of prospective trials. J. Alzheimers Dis. 16, 677\u2013685 (2009).","journal-title":"J. Alzheimers Dis."},{"key":"451_CR111","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2017.01.001","volume":"57","author":"CY Cheung","year":"2017","unstructured":"Cheung, C. Y., Ikram, M. K., Chen, C. & Wong, T. Y. Imaging retina to study dementia and stroke. Prog. Retin. Eye Res. 57, 89\u2013107 (2017).","journal-title":"Prog. Retin. Eye Res."},{"key":"451_CR112","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1167\/iovs.17-23678","volume":"59","author":"JM Sundstrom","year":"2018","unstructured":"Sundstrom, J. M. et al. Proteomic analysis of early diabetic retinopathy reveals mediators of neurodegenerative brain diseases. Invest. Ophthalmol. Vis. Sci. 59, 2264\u20132274 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR113","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","volume":"51","author":"AW Stitt","year":"2016","unstructured":"Stitt, A. W. et al. The progress in understanding and treatment of diabetic retinopathy. Prog. Retin. Eye Res. 51, 156\u2013186 (2016).","journal-title":"Prog. Retin. Eye Res."},{"key":"451_CR114","doi-asserted-by":"publisher","first-page":"E6927","DOI":"10.1073\/pnas.1512683112","volume":"112","author":"Y Wei","year":"2015","unstructured":"Wei, Y. et al. Nrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A. Proc. Natl Acad. Sci. USA 112, E6927\u2013E6936 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"451_CR115","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00125-013-3093-8","volume":"57","author":"Z Xu","year":"2014","unstructured":"Xu, Z. et al. NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia 57, 204\u2013213 (2014).","journal-title":"Diabetologia"},{"key":"451_CR116","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jnc.13064","volume":"133","author":"Z Xu","year":"2015","unstructured":"Xu, Z. et al. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion. J. Neurochem. 133, 233\u2013241 (2015).","journal-title":"J. Neurochem."},{"key":"451_CR117","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1167\/iovs.10-5264","volume":"51","author":"SF Abcouwer","year":"2010","unstructured":"Abcouwer, S. F. et al. Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 51, 5920\u20135933 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR118","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/jcbfm.2013.230","volume":"34","author":"A Muthusamy","year":"2014","unstructured":"Muthusamy, A. et al. Ischemia-reperfusion injury induces occludin phosphorylation\/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner. J. Cereb. Blood Flow. Metab. 34, 522\u2013531 (2014).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"451_CR119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.freeradbiomed.2019.10.414","volume":"146","author":"Q Hui","year":"2020","unstructured":"Hui, Q. et al. Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury. Free Radic. Biol. Med. 146, 181\u2013188 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"451_CR120","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.preteyeres.2011.02.001","volume":"30","author":"AW Stitt","year":"2011","unstructured":"Stitt, A. W. et al. Vascular stem cells and ischaemic retinopathies. Prog. Retin. Eye Res. 30, 149\u2013166 (2011).","journal-title":"Prog. Retin. Eye Res."},{"key":"451_CR121","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/bjo.70.2.114","volume":"70","author":"R Mohan","year":"1986","unstructured":"Mohan, R. & Kohner, E. M. Retinal revascularisation in diabetic retinopathy. Br. J. Ophthalmol. 70, 114\u2013117 (1986).","journal-title":"Br. J. Ophthalmol."},{"key":"451_CR122","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0002-9394(98)00242-6","volume":"126","author":"K Takahashi","year":"1998","unstructured":"Takahashi, K., Kishi, S., Muraoka, K. & Shimizu, K. Reperfusion of occluded capillary beds in diabetic retinopathy. Am. J. Ophthalmol. 126, 791\u2013797 (1998).","journal-title":"Am. J. Ophthalmol."},{"key":"451_CR123","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/01.CIR.99.17.2239","volume":"99","author":"A Abaci","year":"1999","unstructured":"Abaci, A. et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99, 2239\u20132242 (1999).","journal-title":"Circulation"},{"key":"451_CR124","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.2337\/dc13-2547","volume":"37","author":"SL Hernandez","year":"2014","unstructured":"Hernandez, S. L. et al. Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes. Diabetes Care 37, 2193\u20132201 (2014).","journal-title":"Diabetes Care"},{"key":"451_CR125","doi-asserted-by":"publisher","first-page":"848272","DOI":"10.1155\/2015\/848272","volume":"2015","author":"V Altabas","year":"2015","unstructured":"Altabas, V. Diabetes, endothelial dysfunction, and vascular repair: what should a diabetologist keep his eye on? Int. J. Endocrinol. 2015, 848272 (2015).","journal-title":"Int. J. Endocrinol."},{"key":"451_CR126","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1161\/CIRCULATIONAHA.116.024754","volume":"135","author":"J Patel","year":"2017","unstructured":"Patel, J. et al. Functional definition of progenitors versus mature endothelial cells reveals key SoxF-dependent differentiation process. Circulation 135, 786\u2013805 (2017).","journal-title":"Circulation"},{"key":"451_CR127","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-15-2998","volume":"76","author":"H Naito","year":"2016","unstructured":"Naito, H. et al. Endothelial side population cells contribute to tumor angiogenesis and antiangiogenic drug resistance. Cancer Res. 76, 3200\u20133210 (2016).","journal-title":"Cancer Res."},{"key":"451_CR128","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41232-019-0098-9","volume":"39","author":"T Iba","year":"2019","unstructured":"Iba, T. et al. Isolation of tissue-resident endothelial stem cells and their use in regenerative medicine. Inflamm. Regen. 39, 9 (2019).","journal-title":"Inflamm. Regen."},{"key":"451_CR129","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1182\/blood-2004-08-3057","volume":"105","author":"DA Ingram","year":"2005","unstructured":"Ingram, D. A. et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105, 2783\u20132786 (2005).","journal-title":"Blood"},{"key":"451_CR130","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.scr.2008.05.005","volume":"2","author":"JC Kovacic","year":"2009","unstructured":"Kovacic, J. C. & Boehm, M. Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology. Stem Cell Res. 2, 2\u201315 (2009).","journal-title":"Stem Cell Res."},{"key":"451_CR131","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/emboj.2011.465","volume":"31","author":"H Naito","year":"2012","unstructured":"Naito, H., Kidoya, H., Sakimoto, S., Wakabayashi, T. & Takakura, N. Identification and characterization of a resident vascular stem\/progenitor cell population in preexisting blood vessels. EMBO J. 31, 842\u2013855 (2012).","journal-title":"EMBO J."},{"key":"451_CR132","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.stem.2018.01.010","volume":"22","author":"T Wakabayashi","year":"2018","unstructured":"Wakabayashi, T. et al. CD157 marks tissue-resident endothelial stem cells with homeostatic and regenerative properties. Cell Stem Cell 22, 384\u2013397 (2018).","journal-title":"Cell Stem Cell"},{"key":"451_CR133","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jcp.21672","volume":"219","author":"H Sekiguchi","year":"2009","unstructured":"Sekiguchi, H., Ii, M. & Losordo, D. W. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J. Cell Physiol. 219, 235\u2013242 (2009).","journal-title":"J. Cell Physiol."},{"key":"451_CR134","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nm0602-607","volume":"8","author":"MB Grant","year":"2002","unstructured":"Grant, M. B. et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8, 607\u2013612 (2002).","journal-title":"Nat. Med."},{"key":"451_CR135","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1172\/JCI200421686","volume":"114","author":"A Otani","year":"2004","unstructured":"Otani, A. et al. Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J. Clin. Invest. 114, 765\u2013774 (2004).","journal-title":"J. Clin. Invest."},{"key":"451_CR136","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/nm744","volume":"8","author":"A Otani","year":"2002","unstructured":"Otani, A. et al. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8, 1004\u20131010 (2002).","journal-title":"Nat. Med."},{"key":"451_CR137","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/cvr\/cvw209","volume":"112","author":"CL O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, C. L. et al. Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells. Cardiovasc. Res. 112, 677\u2013688 (2016).","journal-title":"Cardiovasc. Res."},{"key":"451_CR138","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/sctm.16-0360","volume":"6","author":"RJ Medina","year":"2017","unstructured":"Medina, R. J. et al. Endothelial progenitors: a consensus statement on nomenclature. Stem Cell Transl. Med. 6, 1316\u20131320 (2017).","journal-title":"Stem Cell Transl. Med."},{"key":"451_CR139","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/scrt122","volume":"3","author":"CL O\u2019Neill","year":"2012","unstructured":"O\u2019Neill, C. L. et al. Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem\/progenitor cells. Stem Cell Res. Ther. 3, 31 (2012).","journal-title":"Stem Cell Res. Ther."},{"key":"451_CR140","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1167\/iovs.14-15415","volume":"56","author":"SS Park","year":"2015","unstructured":"Park, S. S. et al. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest. Ophthalmol. Vis. Sci. 56, 81\u201389 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR141","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/stem.2810","volume":"36","author":"SEJ Chambers","year":"2018","unstructured":"Chambers, S. E. J. et al. The vasoreparative function of myeloid angiogenic cells is impaired in diabetes through the induction of IL1\u03b2. Stem Cells 36, 834\u2013843 (2018).","journal-title":"Stem Cells"},{"key":"451_CR142","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1167\/iovs.09-4951","volume":"51","author":"MJ Medina","year":"2010","unstructured":"Medina, M. J. et al. Outgrowth endothelial cells characterisation and their potential for reversing ischemic retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 5906\u20135913 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"451_CR143","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/stem.1414","volume":"31","author":"RJ Medina","year":"2013","unstructured":"Medina, R. J. et al. Ex-vivo expansion of human endothelial progenitors leads to IL-8-mediated replicative senescence and impaired vasoreparative function. Stem Cells 31, 1657\u20131668 (2013).","journal-title":"Stem Cells"},{"key":"451_CR144","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1538-7836.2009.03407.x","volume":"7","author":"MC Yoder","year":"2009","unstructured":"Yoder, M. C. Defining human endothelial progenitor cells. J. Thromb. Haemost. 7, 49\u201352 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"451_CR145","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/stem.1578","volume":"32","author":"SC Heo","year":"2014","unstructured":"Heo, S. C. et al. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells. Stem Cells 32, 779\u2013790 (2014).","journal-title":"Stem Cells"},{"key":"451_CR146","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/02713683.2019.1681004","volume":"45","author":"PM Bertelli","year":"2020","unstructured":"Bertelli, P. M. et al. Vascular regeneration for ischemic retinopathies: hope from cell therapies. Curr. Eye Res. 45, 372\u2013384 (2020).","journal-title":"Curr. Eye Res."},{"key":"451_CR147","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nbt.3048","volume":"32","author":"N Prasain","year":"2014","unstructured":"Prasain, N. et al. Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells. Nat. Biotechnol. 32, 1151\u20131157 (2014).","journal-title":"Nat. Biotechnol."},{"key":"451_CR148","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/sctm.17-0187","volume":"7","author":"E Reid","year":"2018","unstructured":"Reid, E. et al. Preclinical evaluation and optimization of a cell therapy using human cord blood-derived endothelial colony-forming cells for ischemic retinopathies. Stem Cell Transl. Med. 7, 59\u201367 (2018).","journal-title":"Stem Cell Transl. Med."},{"key":"451_CR149","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89906","volume":"2","author":"S Sakimoto","year":"2017","unstructured":"Sakimoto, S. et al. CD44 expression in endothelial colony-forming cells regulates neurovascular trophic effect. JCI Insight 2, e89906 (2017).","journal-title":"JCI Insight"},{"key":"451_CR150","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.2337\/db14-1030","volume":"64","author":"JM Cahoon","year":"2015","unstructured":"Cahoon, J. M. et al. Intravitreal AAV2.COMP-Ang1 prevents neurovascular degeneration in a murine model of diabetic retinopathy. Diabetes 64, 4247\u20134259 (2015).","journal-title":"Diabetes"},{"key":"451_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065691","volume":"8","author":"TA Mendel","year":"2013","unstructured":"Mendel, T. A. et al. Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS ONE 8, e65691 (2013).","journal-title":"PLoS ONE"},{"key":"451_CR152","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00125-018-4713-0","volume":"61","author":"G Hajmousa","year":"2018","unstructured":"Hajmousa, G. et al. Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells. Diabetologia 61, 2371\u20132385 (2018).","journal-title":"Diabetologia"},{"key":"451_CR153","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/02713683.2019.1669665","volume":"45","author":"R Langhe","year":"2020","unstructured":"Langhe, R. & Pearson, R. A. Rebuilding the retina: prospects for Muller glial-mediated self-repair. Curr. Eye Res. 45, 349\u2013360 (2020).","journal-title":"Curr. Eye Res."},{"key":"451_CR154","doi-asserted-by":"publisher","first-page":"100824","DOI":"10.1016\/j.preteyeres.2019.100824","volume":"76","author":"I Ahmad","year":"2019","unstructured":"Ahmad, I., Teotia, P., Erickson, H. & Xia, X. Recapitulating developmental mechanisms for retinal regeneration. Prog. Retin. Eye Res. 76, 100824 (2019).","journal-title":"Prog. Retin. Eye Res."},{"key":"451_CR155","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/02713683.2019.1697453","volume":"45","author":"D Zerti","year":"2020","unstructured":"Zerti, D., Collin, J., Queen, R., Cockell, S. J. & Lako, M. Understanding the complexity of retina and pluripotent stem cell derived retinal organoids with single cell RNA sequencing: current progress, remaining challenges and future prospective. Curr. Eye Res. 45, 385\u2013396 (2020).","journal-title":"Curr. Eye Res."},{"key":"451_CR156","doi-asserted-by":"publisher","first-page":"E8214","DOI":"10.1073\/pnas.1710430114","volume":"114","author":"CA Galloway","year":"2017","unstructured":"Galloway, C. A. et al. Drusen in patient-derived hiPSC-RPE models of macular dystrophies. Proc. Natl Acad. Sci. USA 114, E8214\u2013E8223 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"451_CR157","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.3390\/ijms20153773","volume":"20","author":"M Kiamehr","year":"2019","unstructured":"Kiamehr, M. et al. Compromised barrier function in human induced pluripotent stem-cell-derived retinal pigment epithelial cells from type 2 diabetic patients. Int. J. Mol. Sci. 20, 3773 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"451_CR158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285\u2013290 (2010).","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1038\/s41574-024-01053-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000}}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00451-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00451-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00451-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:05:59Z","timestamp":1729746359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-00451-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":158,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1038\/s41574-020-00451-4","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"18 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41574-024-01053-0","URL":"https:\/\/doi.org\/10.1038\/s41574-024-01053-0","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.A.A. has received grant support from F. Hoffmann-La Roche, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}